Zhejiang East Asia Pharmaceutical Co., Ltd.SSE: 605177

(605177)"Zhejiang East-Asia Pharmaceutical Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes

· Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 605177 · · 3 pages · Chinese

Summary by 6ix AI

Zhejiang East Asia Pharmaceutical Co., Ltd. announced the results of its convertible bonds conversion and the resulting changes in share capital. As of the end of September, a portion of the convertible bonds has been converted into common shares, affecting the total number of shares outstanding. The filing also details the total amount of convertible bonds that remain unconverted and the adjustments made to the conversion price. The company completed the necessary securities registration changes related to this conversion process.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/605177zhejiang-east-asia-pharmaceutical-co-ltdannouncement-on-conversion-results-of-convertible-bonds-and-share-changes

Release

Announcement on Conversion Results of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang East Asia Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Zhejiang East Asia Pharmaceutical

All Zhejiang East Asia Pharmaceutical news releases